Plasma Biomarkers to Detect Prevalent or Predict Progressive Tuberculosis Associated With Human Immunodeficiency Virus–1 | Zendy

Maia Lesosky | Zendy; Molebogeng X. Rangaka | Zendy; Cara Pienaar | Zendy; Anna K. Coussens | Zendy; René Goliath | Zendy; Shaheed Mathee | Zendy; Judith Mwansa-Kambafwile | Zendy; Gary Maartens | Zendy; Robert J. Wilkinson | Zendy; Katalin A. Wilkinson | Zendy

Open Access

Plasma Biomarkers to Detect Prevalent or Predict Progressive Tuberculosis Associated With Human Immunodeficiency Virus–1

Author(s) -

Maia Lesosky,

Molebogeng X. Rangaka,

Cara Pienaar,

Anna K. Coussens,

René Goliath,

Shaheed Mathee,

Judith Mwansa-Kambafwile,

Gary Maartens,

Robert J. Wilkinson,

Katalin A. Wilkinson

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy823

Subject(s) - medicine , tuberculosis , immunology , analyte , human immunodeficiency virus (hiv) , pathology , chemistry

The risk of individuals infected with human immunodeficiency virus (HIV)-1 developing tuberculosis (TB) is high, while both prognostic and diagnostic tools remain insensitive. The potential for plasma biomarkers to predict which HIV-1-infected individuals are likely to progress to active disease is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research